[go: up one dir, main page]

ES2079570T3 - Nuevas pirido(2,3-f)(1,4)tiazepinas y pirido(3,2-b)(1,5)benzotiazepinas. - Google Patents

Nuevas pirido(2,3-f)(1,4)tiazepinas y pirido(3,2-b)(1,5)benzotiazepinas.

Info

Publication number
ES2079570T3
ES2079570T3 ES91303970T ES91303970T ES2079570T3 ES 2079570 T3 ES2079570 T3 ES 2079570T3 ES 91303970 T ES91303970 T ES 91303970T ES 91303970 T ES91303970 T ES 91303970T ES 2079570 T3 ES2079570 T3 ES 2079570T3
Authority
ES
Spain
Prior art keywords
pirido
new
benzotiazepinas
thiazepines
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91303970T
Other languages
English (en)
Inventor
David J Wustrow
John H Dodd
Charles F Schwender
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Application granted granted Critical
Publication of ES2079570T3 publication Critical patent/ES2079570T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE DESCRIBEN NUEVAS PIRIDO [2,3-F] [1,4] TIACEPINAS Y NUEVAS PIRIDO [3,2-B] [1,5] BENZOTIACEPINAS. ESTOS COMPUESTOS SON UTILES COMO ANTAGONISTAS DEL CANAL DE CALCIO CON ACTIVIDAD CARDIOVASCULAR, ANTIASMATICA Y DE ANTIBRONCO CONSTRICCION. TAMBIEN SE DESCRIBEN METODOS PARA PRODUCIR LOS NUEVOS COMPUESTOS Y SUS INTERMEDIOS.
ES91303970T 1990-05-03 1991-05-02 Nuevas pirido(2,3-f)(1,4)tiazepinas y pirido(3,2-b)(1,5)benzotiazepinas. Expired - Lifetime ES2079570T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/518,351 US5075440A (en) 1990-05-03 1990-05-03 Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines

Publications (1)

Publication Number Publication Date
ES2079570T3 true ES2079570T3 (es) 1996-01-16

Family

ID=24063558

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91303970T Expired - Lifetime ES2079570T3 (es) 1990-05-03 1991-05-02 Nuevas pirido(2,3-f)(1,4)tiazepinas y pirido(3,2-b)(1,5)benzotiazepinas.

Country Status (25)

Country Link
US (1) US5075440A (es)
EP (1) EP0462696B1 (es)
JP (1) JP3296499B2 (es)
KR (1) KR100195345B1 (es)
CN (2) CN1034077C (es)
AT (1) ATE126231T1 (es)
AU (1) AU651580B2 (es)
CA (1) CA2041594C (es)
DE (1) DE69111915T2 (es)
DK (1) DK0462696T3 (es)
ES (1) ES2079570T3 (es)
FI (1) FI95912C (es)
GR (1) GR3017305T3 (es)
HK (1) HK51496A (es)
HU (1) HU218909B (es)
IE (1) IE68524B1 (es)
IL (6) IL120446A (es)
MY (1) MY106552A (es)
NO (1) NO179411C (es)
NZ (1) NZ237988A (es)
PT (1) PT97547B (es)
TN (1) TNSN91030A1 (es)
TW (1) TW218878B (es)
ZA (1) ZA913319B (es)
ZW (1) ZW5291A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
CN1158259C (zh) * 1997-12-18 2004-07-21 艾博特公司 钾通道疏通剂
JPH11193289A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体
US6482854B1 (en) * 1999-03-25 2002-11-19 Massachusetts Eye And Ear Infirmary Glaucoma treatment
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
WO2000077009A1 (en) 1999-06-14 2000-12-21 Ortho-Mcneil Pharmaceutical, Inc. DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
CN1188416C (zh) 1999-07-12 2005-02-09 奥索-麦克尼尔药品公司 氧硫庚英并[6,5－b]二氢吡啶和相关组合物及其制备方法
WO2001021621A1 (en) * 1999-09-22 2001-03-29 Ortho-Mcneil Pharmaceutical, Inc. BENZO-FUSED DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
WO2001051493A1 (en) 2000-01-12 2001-07-19 Ortho-Mcneil Pharmaceutical, Inc. Benzosulfones with calcium antagonist activity
MXPA02007350A (es) 2000-01-27 2004-06-21 Johnson & Johnson Derivados de benzoxatiepino[3,4-b]piridina, procedimiento para su preparacion y su uso como medicamentos.
US6420383B1 (en) 2000-03-23 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Thiepino[3,2-b]dihydropyridines and related compositions and methods
CA2410655A1 (en) 2000-05-30 2001-12-06 John H. Dodd Dihydropyridine compounds for the inhibition of calcium-influx
KR101233139B1 (ko) 2011-04-21 2013-02-21 주식회사 한서켐 라세믹 1,4-티아제핀 화합물의 분할 방법
AU2015374155A1 (en) * 2014-12-30 2017-07-20 Myotherix, Inc. Novel calcium modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587128A (en) * 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
FR2511683A1 (fr) * 1981-08-20 1983-02-25 Hexachimie Nouveaux derives de la pyrido (2,3-b) benzothiazepine(1,5) substituee en 5 par une carboxypiperazine, leur procede de preparation, leur application en therapeutique
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
NZ237988A (en) 1992-09-25
CN1034077C (zh) 1997-02-19
KR100195345B1 (ko) 1999-06-15
NO911723L (no) 1991-11-04
CA2041594C (en) 2002-07-23
IL120446A (en) 2000-08-31
IE911488A1 (en) 1991-11-06
IL120447A (en) 1999-12-22
AU7635491A (en) 1991-11-07
AU651580B2 (en) 1994-07-28
TW218878B (es) 1994-01-11
FI912124A7 (fi) 1991-11-04
ATE126231T1 (de) 1995-08-15
JP3296499B2 (ja) 2002-07-02
IE68524B1 (en) 1996-06-26
IL97999A0 (en) 1992-06-21
CN1039416C (zh) 1998-08-05
CA2041594A1 (en) 1991-11-04
EP0462696A1 (en) 1991-12-27
TNSN91030A1 (fr) 1992-10-25
US5075440A (en) 1991-12-24
DE69111915D1 (de) 1995-09-14
NO911723D0 (no) 1991-05-02
GR3017305T3 (en) 1995-12-31
FI95912C (fi) 1996-04-10
JPH04225986A (ja) 1992-08-14
NO179411B (no) 1996-06-24
DK0462696T3 (da) 1995-09-18
IL127047A (en) 2000-10-31
IL120446A0 (en) 1997-07-13
HUT60745A (en) 1992-10-28
DE69111915T2 (de) 1996-01-04
MY106552A (en) 1995-06-30
HU911476D0 (en) 1991-11-28
KR910020019A (ko) 1991-12-19
CN1056880A (zh) 1991-12-11
CN1118783A (zh) 1996-03-20
IL120447A0 (en) 1997-07-13
FI912124A0 (fi) 1991-05-02
ZW5291A1 (en) 1993-01-06
ZA913319B (en) 1993-01-27
EP0462696B1 (en) 1995-08-09
PT97547B (pt) 1998-08-31
HK51496A (en) 1996-03-29
PT97547A (pt) 1992-01-31
IL127047A0 (en) 1999-09-22
FI95912B (fi) 1995-12-29
HU218909B (hu) 2000-12-28
NO179411C (no) 1996-10-02
IL97999A (en) 1997-06-10

Similar Documents

Publication Publication Date Title
ES2079570T3 (es) Nuevas pirido(2,3-f)(1,4)tiazepinas y pirido(3,2-b)(1,5)benzotiazepinas.
ES2071169T3 (es) 1-indolilalquil-4-(alcoxi-pirimidinil)piperazinas.
IT1107496B (it) Procedimento per la produzione di chinazoline sostituite mediante ciclizzazione di cianocarbossamidine
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
ID21235A (id) Produksi para-xylen terselektif oleh metilasi toluen
FI852906A0 (fi) Foerfarande foer framstaellning av 5h-2,3-bensodiazepin-derivat.
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
ES2188984T3 (es) Procedimiento de enriquecimiento en r de epimeros de derivados de 16,17-acetales de derivados de 21-aciloxi-pregnano-1,4-dieno-11-beta, 16alfa-triol-3,20-dionas.
ES2072784T3 (es) Benzo- y piridopiridonas substituidas con sulfonilbencilo.
ES507430A0 (es) Procedimiento para la produccion de nuevos compuestos de xantato con propiedades farmacologicas.
ATE13667T1 (de) 8-aza-16,16-difluor-prostanoide.
ES539579A0 (es) Procedimiento de fundicion, por deslizamiento, para unidadeshuecas de hormigon, con la maquina necesaria para la practi-ca del mismo
DK305578A (da) Fremgangsmaade til fremstilling af bicycliske thia-diaza-forbindelser isaer 1,3-diaza-cyclopent-2-eno(2,1-b) (1-thia-3-aza-cycloalkaner).
ES2048793T3 (es) Antibioticos antifungicos.
AR228041A1 (es) Procedimiento para producir compuestos de pirazolo(3,4-b)(1,5)benzodiazepina
IT8047961A0 (it) Procedimento per la produzione di copolimeri ad innesto
MY102059A (en) Naphthoxazines
ES2105261T3 (es) Polipeptidos bloqueantes de canales de calcio aislados de filistata hibernalis.
ES2052856T3 (es) Procedimiento para el funcionamiento de instalaciones de conmutacion de telecomunicaciones controladas de forma centralizada.
PT76570B (pt) Antiallergic 4h-furo<3,2-b>indoles
ES2104464T3 (es) Compuestos benzoheterociclicos; como antioxidantes.
DK465377A (da) Fremgangsmaade til fremstilling af cis-isomeren af n,n-dimethyl-9-(3-(4-methyl-1-piperazinyl)propyliden) thioxanthen-2-sulfonamid
ES2005056B3 (es) Cilindro de cierre con oclusion del canal de cierre.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 462696

Country of ref document: ES